Several studies have demonstrated that immune activation caused by vaccination may result in elevation of HIV viral load. Additionally, poor immunization responses are common in HIV-infected children. We therefore studied serologic responses to influenza vaccination and resulting changes in HIV bDNA (Chiron Inc.) in HIV-infected children. Because vitamin A supplementation may enhance immunization responses in vitamin A deficient children, we also determined vitamin A status in the patients, who were then randomized to receive either vitamin A (2 successive daily oral dosages of 200,000 IU) or placebo 2 weeks before vaccination in a double blind study.
Fifty nine children living in Chicago were enrolled (median age 81 mos., range 25-209; CDC immunologic stages 1: n=12, 2: n=25, 3: n=22). There were no differences between vitamin A and placebo supplemented groups at baseline.
Adequate serologic responses to vaccination were demonstrated: influenza strain H1N1 geometric mean titer at vaccination was 13.43±1.19 and 1 mo. later 33.11±1.23 (p<0.001); for strain H3N2 16.98±1.19 and 49.43±1.22, respectively (p<0.001). More severely immunocompromised patients (CDC stage 3) had significantly worse responses to strain H1N1 when compared to less immunocompromised children (p=0.04), but not to strain H3N2 (p=0.08). Vaccination did not result in a change in plasma bDNA: mean logbDNA at vaccination was 3.98±1.01, 2 wks. later 3.93±0.14 (p=0.89), 4 wks. later 3.92±0.15 (p=0.86). Plasma vitamin A levels were normal (>20mg/dL) in the majority (n=47, 79%) and low in 12 patients (21%); median level was 25.1 mg/dL, range 11-150. No difference in influenza vaccination response was demonstrated between vitamin A and placebo supplemented groups (H1N1: p=0.151, H3N2: p=0.706).
We conclude that serologic response to influenza vaccination was adequate in our cohort of HIV-infected children. Worse serologic responses were demonstrated in more immunocompromised children. Influenza vaccination did not result in change in HIV viral load. Vitamin A supplementation did not enhance serologic response to vaccination. However, this finding may be explained by adequate vitamin A status in our cohort; the role of vitamin A supplementation in vitamin A deficient HIV-infected children should be studied further.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hanekom, W., Heald, L., Hussey, G. et al. Influenza Vaccination in HIV-Infected Children: Serologic Response, Viral Load Changes and Effect of Vitamin A Supplementation ♦ 844. Pediatr Res 43 (Suppl 4), 146 (1998). https://doi.org/10.1203/00006450-199804001-00865
Issue Date:
DOI: https://doi.org/10.1203/00006450-199804001-00865